Skip to content
Checked.be
Complete company report
Generated 29-06-2026
Active BE 0502.703.389Public limited company

ETHERNA IMMUNOTHERAPIES

Galileilaan 19 ·2845 Niel, Belgium· 13 yrs active
Sector: NACE 72109 (72109)
Conclusion Checked

The computed 12-month bankruptcy probability of ETHERNA IMMUNOTHERAPIES is 0.5% (low). The company has been active since 2013 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.
Key figures
Active 13 yrs
Locations 3
Publications 49
Bankruptcy probability (12 mo) Checked model v1 · free
0.5% Low
0%0,5%1,5%4%10%≥25%
Multiple establishment units +Lower-failure-rate sector −Lower-risk legal form −

Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based
0 / 100
Low risk
Trust signals 3 signals
Established
Founded in 2013 — 13 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags 0 events
No administrative flags
Financial overview10 NBB filings
Financials being processed
NBB has 10 filing(s) on record for this company — latest fiscal year 2025 (volledig). The annual accounts are being processed.
Filings on record
Fiscal year Type Filed Reference
31-12-2025 volledig 29-05-2026 2026-00143865
31-12-2024 volledig 27-05-2025 2025-00109335
31-12-2023 volledig 07-05-2024 2024-00084605
31-12-2022 volledig 09-05-2023 2023-00085510
31-12-2021 verkort 23-05-2022 2022-20033679
31-12-2020 verkort 19-05-2021 2021-14600419
31-12-2019 verkort 15-07-2020 2020-30400454
31-12-2018 verkort 22-05-2019 2019-14000187
31-12-2017 verkort 23-05-2018 2018-13600300
31-12-2016 verkort 18-05-2017 2017-12800443
Legal Structure
NACE primary 72109
Legal form Public limited company(014)
Incorporation21-01-2013
StatusActive
Postal code2845
Establishment units 3 locations
ETHERNA
Frieda Saeysstraat 1B, 9052 GentVervaardiging van farmaceutische grondstoffen
since 20132.216.517.702
etherna immunotherapies NV
Galileilaan 19, 2845 NielVervaardiging van farmaceutische grondstoffen
since 20162.254.349.383
Galileilaan 21, 2845 Niel
Vervaardiging van farmaceutische grondstoffen
since 20192.327.085.230
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates — not a deeds register.

Flanders 3 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44082B0663/00B000 Flanders 4,783 m² 1 · 1,373 m² 1.9 m
11030C0056/00B000 Flanders 3,722 m² 1 · 1,022 m² 13.3 m · 4 fl.
11030C0356/00A000 Flanders 3,329 m² 1 · 304 m² 14.4 m · 2 fl.
Methodology
via registered seat: 1 · via establishment units: 2
3 of 3 parcels with an exact address match; the rest are indicative.
Linked through address data — this is not proof of ownership.
Updates 59 events

A single timeline of everything that happened to this company — publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2026
29-05-2026
NBB filing Annual accounts filed
fiscal year 2025 · volledig
2025
27-05-2025
NBB filing Annual accounts filed
fiscal year 2024 · volledig
18-03-2025
State Gazette act Statutes amendment
Lars HANSEN
18-03-2025
State Gazette act Capital & shares
Lars HANSEN
18-03-2025
State Gazette act Statutes amendment
v3.2
18-03-2025
State Gazette act Capital & shares
v3.2
2024
05-11-2024
State Gazette act Director changes
v3.2
05-11-2024
State Gazette act Director changes
25-06-2024
State Gazette act Miscellaneous
other · Lars HANSEN
25-06-2024
State Gazette act Statutes amendment
Lars HANSEN
25-06-2024
State Gazette act Statutes amendment
v3.2
10-06-2024
State Gazette act Director changes
v3.2
10-06-2024
State Gazette act Director changes
07-05-2024
NBB filing Annual accounts filed
fiscal year 2023 · volledig
2023
16-06-2023
State Gazette act Director changes
v3.2
09-05-2023
NBB filing Annual accounts filed
fiscal year 2022 · volledig
06-04-2023
State Gazette act Director changes
06-04-2023
State Gazette act Director changes
v3.2
2022
05-10-2022
State Gazette act Director changes
v3.2
22-08-2022
State Gazette act Statutes amendment
v3.2
22-08-2022
State Gazette act Director changes
v3.2
22-08-2022
State Gazette act Capital & shares
v3.2
29-07-2022
State Gazette act Director changes
v3.2
23-05-2022
NBB filing Annual accounts filed
fiscal year 2021 · verkort
07-02-2022
State Gazette act Director changes
v3.2
2021
03-12-2021
State Gazette act Director changes
v3.2
19-05-2021
NBB filing Annual accounts filed
fiscal year 2020 · verkort
04-02-2021
State Gazette act Capital & shares
v3.2
04-02-2021
State Gazette act Statutes amendment
v3.2
2020
11-08-2020
State Gazette act Miscellaneous
other · Marc SLEDSENS
11-08-2020
State Gazette act Capital & shares
v3.2
15-07-2020
NBB filing Annual accounts filed
fiscal year 2019 · verkort
07-07-2020
State Gazette act Director changes
v3.2
01-07-2020
State Gazette act Director changes
v3.2
01-07-2020
State Gazette act Statutes amendment
v3.2
01-07-2020
State Gazette act Capital & shares
v3.2
06-05-2020
State Gazette act Director changes
v3.2
2019
25-07-2019
State Gazette act Director changes
v3.2
25-07-2019
State Gazette act Miscellaneous
other · Marc SLEDSENS
25-07-2019
State Gazette act Capital & shares
v3.2
22-05-2019
NBB filing Annual accounts filed
fiscal year 2018 · verkort
26-02-2019
State Gazette act Director changes
v3.2
11-02-2019
State Gazette act Capital & shares
v3.2
2018
05-11-2018
State Gazette act Director changes
v3.2
23-05-2018
NBB filing Annual accounts filed
fiscal year 2017 · verkort
07-05-2018
State Gazette act Statutes amendment
v3.2
07-05-2018
State Gazette act Capital & shares
v3.2
08-02-2018
State Gazette act Director changes
v3.2
29-01-2018
State Gazette act Director changes
v3.2
04-01-2018
State Gazette act Capital & shares
v3.2
2017
18-05-2017
NBB filing Annual accounts filed
fiscal year 2016 · verkort
18-05-2017
State Gazette act Capital & shares
v3.2
18-05-2017
State Gazette act Statutes amendment
v3.2
2016
08-12-2016
State Gazette act Director changes
v3.2
05-10-2016
State Gazette act Director changes
v3.2
19-04-2016
State Gazette act Capital & shares
v3.2
19-04-2016
State Gazette act Registered-office change
Marc Sledgens
19-04-2016
State Gazette act Statutes amendment
v3.2
2015
19-06-2015
State Gazette act Director changes
v3.2
Belgisch Staatsblad — acts 49 acts
Capital history · 12
18-03-2025
Capital change
18-03-2025
v3.2
22-08-2022
v3.2
04-02-2021
v3.2
11-08-2020
v3.2
01-07-2020
v3.2
25-07-2019
v3.2
11-02-2019
v3.2
07-05-2018
v3.2
04-01-2018
v3.2
18-05-2017
v3.2
19-04-2016
v3.2
Address history · 1
19-04-2016
Registered-office move
All acts · 49 updated 1 year ago
2025
18-03-2025 Articles of association amended — translation of the articles, coordination of the articles and amendment of specific articles Statutes amendment·Lars HANSEN
Notary: Lars HANSEN · AntwerpenFirm: Deckers notarissen
Technical details 
{
  "notary": {
    "name": "Lars HANSEN",
    "firm_city": null,
    "firm_name": "Deckers notarissen",
    "office_city": "Antwerpen",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2025-03-18",
    "filing_date": "2025-03-14",
    "act_kind_objet": "STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN), KAPITAAL, AANDELEN"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2025-02-27",
    "unanimous": true
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "targeted_amendment"
    ],
    "scope": "full_restatement",
    "trigger": "capital_change_consequence",
    "language_after": "nl",
    "language_before": "nl"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full_after": "ETHERNA IMMUNOTHERAPIES",
    "legal_form_after": "Naamloze vennootschap",
    "name_full_before": "ETHERNA IMMUNOTHERAPIES",
    "current_zetel_raw": "Galileilaan 19 2845 Niel",
    "legal_form_before": "Naamloze vennootschap"
  },
  "special_mandates": [],
  "articles_modified": [
    {
      "summary": "The article was replaced with a new text detailing the increased capital of \u20AC1,979,105.59 represented by 1,478,585 shares across four classes.",
      "new_text": "-1. Geplaatst kapitaal\nHet geplaatst kapitaal bedraagt EEN MILJOEN NEGENHONDERDNEGENENZEVENTIGDUIZEND\nHONDERDENVIJF EURO NEGENENVIJFTIG CENT (\u20AC 1.979.105,59), vertegenwoordigd door EEN\nMILJOEN VIERHONDERDACHTENZEVENTIGDUIZEND VIJFHONDERDVIJFENTACHTIG",
      "change_kind": "replaced",
      "article_title": null,
      "article_number": "5-1."
    }
  ],
  "governance_change": null,
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Lars HANSEN",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "afschrift van de akte",
    "lijst van warranten",
    "geco\u00F6rdineerde tekst van de statuten en historiek van de statutenwijzigingen"
  ],
  "shareholder_rights": {
    "quorum_rules_changed": false,
    "liquidation_preference_text": null,
    "voorkeurrecht_rules_changed": true,
    "aandelenoverdracht_restrictions_changed": true
  },
  "voorwerp_change_summary": null,
  "capital_structure_change": {
    "operations": [
      "capital_increase_cash",
      "share_class_creation"
    ],
    "split_ratio": null,
    "shares_after": 1478585,
    "shares_before": 1478585,
    "capital_after_eur": 1979105.59,
    "capital_before_eur": 1979105.59,
    "share_classes_after": [
      {
        "count": 46536,
        "label": "Gewone Aandelen",
        "rights_summary": "Same rights and benefits as existing Ordinary Shares",
        "voting_per_share": 1.0
      },
      {
        "count": 338981,
        "label": "Bevoorrechte Klasse A Aandelen",
        "rights_summary": "Same rights and benefits as existing Ordinary Shares",
        "voting_per_share": 1.0
      },
      {
        "count": 575078,
        "label": "Bevoorrechte Klasse B1 Aandelen",
        "rights_summary": "Same rights and benefits as existing Ordinary Shares",
        "voting_per_share": 1.0
      },
      {
        "count": 517990,
        "label": "Bevoorrechte Klasse B2 Aandelen",
        "rights_summary": "Same rights and benefits as existing Ordinary Shares",
        "voting_per_share": 1.0
      }
    ]
  },
  "coordinated_text_lineage": null
}
18-03-2025 Capital increase of €550.74 to €1,979,656.33 Capital & shares·Lars HANSEN
  • €1.979.105,59 → €1.979.656,33
Notary: Lars HANSEN · AntwerpenFirm: Deckers notarissen
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 1979656.33,
      "delta_eur": 550.74,
      "before_eur": 1979105.59,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "houder van Stock Optie Warrants",
          "share_class": "Gewone Aandelen",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 411,
          "contribution_amount_eur": 550.74
        }
      ],
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": "Gewone Aandelen",
        "n_new_shares": 411,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": 550.74,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Lars HANSEN",
    "firm_city": null,
    "firm_name": "Deckers notarissen",
    "office_city": "Antwerpen",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2025-03-18",
    "filing_date": "2025-03-14",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2025-02-27",
    "unanimous": null,
    "under_authorized_capital": true,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES",
    "legal_form": "Naamloze vennootschap",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "afschrift van de akte",
    "lijst van warranten",
    "geco\u00F6rdineerde tekst van de statuten en historiek van de statutenwijzigingen"
  ],
  "shareholders_after": [
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "houder van Stock Optie Warrants",
      "role": null,
      "n_shares": 1478585,
      "share_class": null
    }
  ],
  "share_classes_after": [
    {
      "n_shares": 46536,
      "class_name": "Gewone Aandelen",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 338981,
      "class_name": "Bevoorrechte Klasse A Aandelen",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 575078,
      "class_name": "Bevoorrechte Klasse B Aandelen",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 517990,
      "class_name": "Bevoorrechte Klasse B2 Aandelen",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    }
  ]
}
18-03-2025 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  },
  "legal_form_change": {
    "new": "Naamloze vennootschap",
    "old": "Naamloze vennootschap",
    "changed": false
  }
}
18-03-2025 Capital increase of €550.74 to €1,979,105.59 Capital & shares
  • €1.978.554,85 → €1.979.105,59
  • Inbreng in geld · Apport en numéraire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 1979105.59,
      "delta_eur": 550.7399999999907,
      "before_eur": 1978554.85,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}
2024
05-11-2024 2 directors appointed Director changes
  • Didier Delanoye — Commissaris
  • Antonin de Fougerolles — Voorzitter raad van bestuur
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Didier Delanoye",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "voorzitter raad van bestuur",
      "person": {
        "rrn": null,
        "name": "Antonin de Fougerolles",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}
05-11-2024 2 directors appointed, 1 reappointed Director changes
  • Didier Delanoye — Commissaris
  • Antonin de Fougerolles — Voorzitter
  • Antonin de Fougerolles — Voorzitter
Technical details 
{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": "A02154",
        "name": "Didier Delanoye",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": {
        "kbo": null,
        "name": "PwC Bedrijfsrevisoren BV",
        "address": "1831 Diegem, Culliganlaan 5",
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering van aandeelhouders beslist met eenparigheid van stemmen om PwC Bedrijfsrevisoren BV (B0009), met maatschappelijke zetel te 1831 Diegem, Culliganlaan 5, vertegenwoordigd door de Heer Didier Delanoye (A02154), te herbenoemen als commissaris van de vennootschap en dit voor een p",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "3"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": null,
      "person": null,
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering verleent een bijzondere volmacht aan iedere bestuurder van de vennootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, mevrouw Sofie Van Paesschen, de heer Nicolas Bosschaerts, en iedere advocaat of werknemer van Deloitte Legal, c/o Deloitte Legal, Gat",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "voorzitter",
      "person": {
        "rrn": null,
        "name": "Antonin de Fougerolles",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "successor_conditional",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "de heer Antonin de Fougerolles wordt benoemd als nieuwe voorzitter van de raad van bestuur",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "mandate_confirmation",
      "role": "voorzitter",
      "person": {
        "rrn": null,
        "name": "Antonin de Fougerolles",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "confirmation",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "de benoeming van de heer Antonin de Fougerolles te bekrachtigen als voorzitter van de raad van bestuur van de Vennootschap, met ingang vanaf de datum van ondertekening van deze notulen",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "decharge_granted",
      "role": null,
      "person": {
        "rrn": null,
        "name": "Antonin de Fougerolles",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "het vergoedingspakket van de heer Antonin de Fougerolles voor zijn rol als voorzitter van de raad van bestuur, zoals hierboven voorgesteld en goedgekeurd door de raad van bestuur, te bekrachtigen",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Antwerpen",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2024-11-05",
    "filing_date": "2024-06-26",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2024-04-23",
      "unanimous": true
    },
    {
      "body": "algemene_vergadering",
      "date": "2024-06-26",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES",
    "legal_form": "NV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Nicolas Bosschaerts",
    "org_rep_person_name": null,
    "person_role_at_subject": "Bijzonder gevolmachtigde"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}
25-06-2024 Publication in the Belgian Official Gazette — Miscellaneous Miscellaneous·Lars HANSEN
Summary: otherNotary: Lars HANSEN · AntwerpenFirm: Deckers notarissen
Technical details 
{
  "stage": null,
  "notary": {
    "name": "Lars HANSEN",
    "firm_city": null,
    "firm_name": "Deckers notarissen",
    "office_city": "Antwerpen",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-06-25",
    "filing_date": "2024-06-21",
    "act_kind_objet": "STATUTEN (VERTALING, COORDINATIE, OVERIGE"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2024-06-17",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0502.703.389",
        "name": "ETHERNA IMMUNOTHERAPIES",
        "role": "other",
        "address": "Galileilaan 19, 2845 Niel",
        "is_foreign": false,
        "legal_form": "Naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "7:180",
      "7:187",
      "184 WIB"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 106363,
    "real_estate_included": false,
    "patrimony_description": "De besluiten betreffen de uitgifte van 106.363 Stock Optie Warrants en de verhogen van het kapitaal van de vennootschap op basis van de uitoefenprijs van deze opties. Het kapitaal wordt verhoogd indien de opties worden uitgeoefend, met een eventueel deel van het verschil tussen uitoefenprijs en fractiewaarde op een onbeschikbare rekening \u0027uitgiftepremie\u0027.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES",
    "legal_form": "Naamloze vennootschap"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "Deloitte Legal-Lawyers",
    "person_name": null,
    "org_rep_person_name": "Henri-Simon Vande Vyver, Filip Van Acoleyen, Nicolas Bosschaerts"
  },
  "summary_narrative": "De buitengewone algemene vergadering van ETHERNA IMMUNOTHERAPIES besliste de vernietiging van 49.536 vervallen Stock Optie Warrants en de uitgifte van 106.363 nieuwe Stock Optie Warrants volgens het Aandelenoptieplan 2024. Daarnaast werd het kapitaal van de vennootschap verhoogd op basis van de uitoefenprijzen van de uitgeoefende opties, met een specifieke boekhoudkundige behandeling van eventuele premies. De bestuurders kregen volmacht om de vereiste formaliteiten uit te voeren.",
  "co_filed_documents": [
    "volmachten",
    "aandelenoptieplan",
    "verslagen van de raad van bestuur",
    "verslagen van de commissaris",
    "geco\u00F6rdineerde tekst van de statuten en historiek van de statutenwijzigingen"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "capital_shares"
}
25-06-2024 Articles of association amended — translation of the articles and coordination of the articles Statutes amendment·Lars HANSEN
Notary: Lars HANSEN · AntwerpenFirm: Deckers notarissen
Technical details 
{
  "notary": {
    "name": "Lars HANSEN",
    "firm_city": null,
    "firm_name": "Deckers notarissen",
    "office_city": "Antwerpen",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-06-25",
    "filing_date": "2024-06-21",
    "act_kind_objet": "STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN), DIVERSEN"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2024-06-17",
    "unanimous": null
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "other"
    ],
    "scope": null,
    "trigger": null,
    "language_after": null,
    "language_before": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full_after": "ETHERNA IMMUNOTHERAPIES",
    "legal_form_after": "Naamloze vennootschap",
    "name_full_before": "ETHERNA IMMUNOTHERAPIES",
    "current_zetel_raw": "Galileilaan 19, 2845 Niel",
    "legal_form_before": "Naamloze vennootschap"
  },
  "special_mandates": [
    {
      "holder_kbo": null,
      "holder_name": "Henri-Simon Vande Vyver",
      "scope_categories": [
        "kbo",
        "ubo",
        "btw"
      ],
      "with_substitution": true
    },
    {
      "holder_kbo": null,
      "holder_name": "Filip Van Acoleyen",
      "scope_categories": [
        "kbo",
        "ubo",
        "btw"
      ],
      "with_substitution": true
    },
    {
      "holder_kbo": null,
      "holder_name": "Nicolas Bosschaerts",
      "scope_categories": [
        "kbo",
        "ubo",
        "btw"
      ],
      "with_substitution": true
    },
    {
      "holder_kbo": null,
      "holder_name": "Deloitte Legal-Lawyers",
      "scope_categories": [
        "kbo",
        "ubo",
        "btw"
      ],
      "with_substitution": true
    }
  ],
  "articles_modified": [
    {
      "summary": "Vaststelling van de uitgifte- en uitoefenvoorwaarden van de Stock Optie Warrants.",
      "new_text": null,
      "change_kind": "amended",
      "article_title": null,
      "article_number": "7:180"
    },
    {
      "summary": "Wijziging van de rechten verbonden aan elke soort aandelen.",
      "new_text": null,
      "change_kind": "amended",
      "article_title": null,
      "article_number": "7:155"
    },
    {
      "summary": "Regelgeving voor het op een afzonderlijke rekening onder het eigen vermogen op het passief van de balans vermelden van het bedrag.",
      "new_text": null,
      "change_kind": "amended",
      "article_title": null,
      "article_number": "184"
    }
  ],
  "governance_change": {
    "organ_kind_after": null,
    "organ_kind_before": null,
    "admin_delegated_added": [
      {
        "name": "Henri-Simon Vande Vyver",
        "excluded_powers": []
      },
      {
        "name": "Filip Van Acoleyen",
        "excluded_powers": []
      },
      {
        "name": "Nicolas Bosschaerts",
        "excluded_powers": []
      },
      {
        "name": "iedere andere advocaat of medewerker van Deloitte Legal-Lawyers",
        "excluded_powers": []
      }
    ],
    "representation_rule_after": null,
    "co_signature_threshold_eur": null,
    "representation_rule_before": null
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Lars HANSEN",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "afschrift van de akte",
    "volmachten",
    "aandelenoptieplan",
    "verslagen van de raad van bestuur",
    "verslagen van de commissaris",
    "geco\u00F6rdineerde tekst van de statuten en historiek van de statutenwijzigingen"
  ],
  "shareholder_rights": null,
  "voorwerp_change_summary": null,
  "capital_structure_change": {
    "operations": [
      "eigen_aandelen_inkoop",
      "eigen_aandelen_vernietigen",
      "share_class_creation",
      "capital_increase_cash"
    ],
    "split_ratio": null,
    "shares_after": null,
    "shares_before": null,
    "capital_after_eur": null,
    "capital_before_eur": null,
    "share_classes_after": [
      {
        "count": null,
        "label": "nieuwe aandelen",
        "rights_summary": "De uitgifte van de nieuwe aandelen zal niet evenredig aan het aantal uitgegeven aandelen binnen elke soort gebeuren, hetgeen een wijziging van de rechten verbonden aan elke soort inhoudt.",
        "voting_per_share": null
      }
    ]
  },
  "coordinated_text_lineage": null
}
25-06-2024 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  },
  "legal_form_change": {
    "new": "",
    "old": "Naamloze vennootschap",
    "changed": false
  }
}
10-06-2024 2 directors appointed, 1 resigning Director changes
  • Bernard Sagaert — Ceo
  • Marijn Dekkers — Voorzitter raad van bestuur
  • Russell Greig — Voorzitter raad van bestuur
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "CEO",
      "person": {
        "rrn": null,
        "name": "Bernard Sagaert",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "voorzitter raad van bestuur",
      "person": {
        "rrn": null,
        "name": "Russell Greig",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "voorzitter raad van bestuur",
      "person": {
        "rrn": null,
        "name": "Marijn Dekkers",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}
10-06-2024 7 directors appointed, 2 resigning Director changes
  • Inphacon BV — Commissaris
  • Marijn Dekkers — Voorzitter
  • Nicolas Bosschaerts — Dagelijks bestuur
  • Christoph Michiels — Dagelijks bestuur
  • Henri-Simon Vande Vyver — Dagelijks bestuur
  • Sofie Van Paesschen — Dagelijks bestuur
  • Deloitte Legal - Lawyers BV — Dagelijks bestuur
  • Russell Greig — Bestuurder
Technical details 
{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Inphacon BV",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2023-09-21",
      "evidence_quote": "De Raad heeft unaniem de benoeming van Inphacon BV, met Bernard Sagaert als vaste vertegenwoordiger, goedgekeurd voor de functie van CEO, met ingang van 21 september 2023, voor onbepaalde duurtijd.",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Russell Greig",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "Greig Biotechnology Global Consulting Inc.",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "statutory": null,
      "compensated": null,
      "effective_date": "2023-09-22",
      "evidence_quote": "Russell Greig, optredend in zijn hoedanigheid als vaste vertegenwoordiger van Greig Biotechnology Global Consulting Inc., heeft de Raad op de hoogte gesteld van zijn beslissing om af te treden als bestuurder en voorzitter van de Raad.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_out",
      "role": "voorzitter",
      "person": {
        "rrn": null,
        "name": "Russell Greig",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "Greig Biotechnology Global Consulting Inc.",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "statutory": null,
      "compensated": null,
      "effective_date": "2023-09-22",
      "evidence_quote": "De Raad heeft kennis genomen van het ontslag van Greig Biotechnology Global Consulting Inc., met Russell Greig als vaste vertegenwoordiger, als bestuurder en voorzitter van de Vennootschap, met ingang van 22 september 2023.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "voorzitter",
      "person": {
        "rrn": null,
        "name": "Marijn Dekkers",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Marijn Dekkers, als tweede oudste lid van de Raad, stemde ermee in om als voorzitter te fungeren, in afwachting van de definitieve benoeming van een nieuwe voorzitter door de aandeelhoudersvergadering overeenkomstig artikel 11 van de statuten.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Nicolas Bosschaerts",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "Deloitte Legal - Lawyers BV",
        "address": "Brussels National Airport 1 J, 1930 Zaventem, Belgi\u00EB",
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De Raad heeft unaniem besloten om een bijzondere volmacht te verlenen aan iedere bestuurder van de Vennootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, mevrouw Sofie Van Paesschen, de heer Nicolas Bosschaerts en iedere advocaat of werknemer van Deloitte Legal - Lawyers BV",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Christoph Michiels",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "Deloitte Legal - Lawyers BV",
        "address": "Brussels National Airport 1 J, 1930 Zaventem, Belgi\u00EB",
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De Raad heeft unaniem besloten om een bijzondere volmacht te verlenen aan iedere bestuurder van de Vennootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, mevrouw Sofie Van Paesschen, de heer Nicolas Bosschaerts en iedere advocaat of werknemer van Deloitte Legal - Lawyers BV",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Henri-Simon Vande Vyver",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "Deloitte Legal - Lawyers BV",
        "address": "Brussels National Airport 1 J, 1930 Zaventem, Belgi\u00EB",
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De Raad heeft unaniem besloten om een bijzondere volmacht te verlenen aan iedere bestuurder van de Vennootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, mevrouw Sofie Van Paesschen, de heer Nicolas Bosschaerts en iedere advocaat of werknemer van Deloitte Legal - Lawyers BV",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Sofie Van Paesschen",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "Deloitte Legal - Lawyers BV",
        "address": "Brussels National Airport 1 J, 1930 Zaventem, Belgi\u00EB",
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De Raad heeft unaniem besloten om een bijzondere volmacht te verlenen aan iedere bestuurder van de Vennootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, mevrouw Sofie Van Paesschen, de heer Nicolas Bosschaerts en iedere advocaat of werknemer van Deloitte Legal - Lawyers BV",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": null,
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "Deloitte Legal - Lawyers BV",
        "address": "Brussels National Airport 1 J, 1930 Zaventem, Belgi\u00EB",
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De Raad heeft unaniem besloten om een bijzondere volmacht te verlenen aan iedere bestuurder van de Vennootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, mevrouw Sofie Van Paesschen, de heer Nicolas Bosschaerts en iedere advocaat of werknemer van Deloitte Legal - Lawyers BV",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-06-10",
    "filing_date": "2024-05-15",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decisions": [
    {
      "body": "raad_van_bestuur",
      "date": "2023-09-21",
      "unanimous": true
    },
    {
      "body": "raad_van_bestuur",
      "date": "2023-09-22",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES",
    "legal_form": "NV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Nicolas Bosschaerts",
    "org_rep_person_name": null,
    "person_role_at_subject": "bestuurder"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}
2023
16-06-2023 21-23 NEWELL ROAD LLC appointed as onafhankelijke bestuurder Director changes
  • 21-23 NEWELL ROAD LLC — Onafhankelijke bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "onafhankelijke bestuurder",
      "person": {
        "rrn": null,
        "name": "21-23 NEWELL ROAD LLC",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}
06-04-2023 8 directors appointed Director changes
  • Antonin Rollet De Fougerolles — Bestuurder
  • Christoph Michiels — Dagelijks bestuur
  • Henri-Simon Vande Vyver — Dagelijks bestuur
  • Roan Asselman — Dagelijks bestuur
  • Nicolas Bosschaerts — Dagelijks bestuur
  • Anthea Debou — Dagelijks bestuur
  • Deloitte Legal — Dagelijks bestuur
  • Deloitte Legal — Dagelijks bestuur
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Antonin Rollet De Fougerolles",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2022-12-21",
      "evidence_quote": "De voorzitter stelt vast dat, op basis van de stemmen uitgebracht per stembrief, zijnde alle uitgebrachte stemmen op deze bijzondere algemene vergadering, de volgende besluiten zijn genomen door de algemene vergadering van aandeelhouders: \u2022 Aanstelling van Antonin Rollet De Fougerolles als onafhanke",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "6"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "decharge_granted",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Antonin Rollet De Fougerolles",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering verleent een bijzondere volmacht aan iedere bestuurder van de Venriootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, de heer Roan Asselman, de heer Nicolas Bosschaerts, mevrouw Anthea Debou en iedere advocaat of werknemer van Deloitte Legal, c/o Del",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Christoph Michiels",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering verleent een bijzondere volmacht aan iedere bestuurder van de Venriootschap en aan de heer Christoph Michiels",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Henri-Simon Vande Vyver",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering verleent een bijzondere volmacht aan iedere bestuurder van de Venriootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Roan Asselman",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering verleent een bijzondere volmacht aan iedere bestuurder van de Venriootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, de heer Roan Asselman",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Nicolas Bosschaerts",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering verleent een bijzondere volmacht aan iedere bestuurder van de Venriootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, de heer Roan Asselman, de heer Nicolas Bosschaerts",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Anthea Debou",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering verleent een bijzondere volmacht aan iedere bestuurder van de Venriootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, de heer Roan Asselman, de heer Nicolas Bosschaerts, mevrouw Anthea Debou",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": null,
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "Deloitte Legal",
        "address": "Gateway Building, Luchthaven Brussel Nationaal 1 J, 1930 Zaventem, Belgi\u00EB",
        "country": "BE",
        "legal_form": null
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering verleent een bijzondere volmacht aan iedere bestuurder van de Venriootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, de heer Roan Asselman, de heer Nicolas Bosschaerts, mevrouw Anthea Debou en iedere advocaat of werknemer van Deloitte Legal",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": null,
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "Deloitte Legal",
        "address": "Gateway Building, Luchthaven Brussel Nationaal 1 J, 1930 Zaventem, Belgi\u00EB",
        "country": "BE",
        "legal_form": null
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering verleent een bijzondere volmacht aan iedere bestuurder van de Venriootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, de heer Roan Asselman, de heer Nicolas Bosschaerts, mevrouw Anthea Debou en iedere advocaat of werknemer van Deloitte Legal",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Antwerpen",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": null,
    "filing_date": "2023-03-20",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decisions": [
    {
      "body": "bijzondere_algemene_vergadering",
      "date": "2022-12-21",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES",
    "legal_form": "NV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Anthea Debou",
    "org_rep_person_name": null,
    "person_role_at_subject": "Bijzonder gevolmachtigde"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}
06-04-2023 Antonin Rollet De Fougerolles appointed as onafhankelijke bestuurder Director changes
  • Antonin Rollet De Fougerolles — Onafhankelijke bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "onafhankelijke bestuurder",
      "person": {
        "rrn": null,
        "name": "Antonin Rollet De Fougerolles",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}
2022
05-10-2022 2 directors appointed, 2 resigning Director changes
  • Inphacon BV — Interim ceo and person responsible for daily management
  • Inphacon BV — Board member
  • The Truffaldino Partnership Limited — Ceo and person responsible for daily management
  • The Truffaldino Partnership Limited — Board member
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "CEO and person responsible for daily management",
      "person": {
        "rrn": null,
        "name": "The Truffaldino Partnership Limited",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "interim CEO and person responsible for daily management",
      "person": {
        "rrn": null,
        "name": "Inphacon BV",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "board member",
      "person": {
        "rrn": null,
        "name": "The Truffaldino Partnership Limited",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "board member",
      "person": {
        "rrn": null,
        "name": "Inphacon BV",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}
22-08-2022 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": true
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  },
  "legal_form_change": {
    "new": "naamloze vennootschap",
    "old": "naamloze vennootschap",
    "changed": false
  }
}
22-08-2022 3 directors appointed, 5 resigning Director changes
  • CHIEN Kenneth Randall — Bestuurder
  • DEKKERS Marinus Emmanuel — Bestuurder
  • Biotech Fonds Vlaanderen — Bestuurder
  • PARTICIPATIEMAATSCHAPPIJ VLAANDEREN — Bestuurder
  • Vincent OSSIPOW — Bestuurder
  • Vianova SPRL — Bestuurder
  • Chris BUYSE — Bestuurder
  • Yijun CHEN — Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "CHIEN Kenneth Randall",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "DEKKERS Marinus Emmanuel",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "PARTICIPATIEMAATSCHAPPIJ VLAANDEREN",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Vincent OSSIPOW",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Vianova SPRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Chris BUYSE",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Yijun CHEN",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Biotech Fonds Vlaanderen",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}
22-08-2022 Capital increase of €29,906,957.29 to €31,885,512.14 Capital & shares
  • €1.978.554,85 → €31.885.512,14
  • Inbreng in geld · Apport en numéraire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 31885512.14,
      "delta_eur": 29906957.29,
      "before_eur": 1978554.85,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}
29-07-2022 5 directors appointed, 3 resigning Director changes
  • Chris Buyse — Bestuurder
  • Russeil Greig — Onafhankelijke bestuurder
  • John de Koning — Bestuurder
  • Vincent Ossipow — Bestuurder
  • Vincent Brichard — Onafhankelijke bestuurder
  • Alexandra Tolia — Bestuurder
  • Frank Kalkbrenner — Bestuurder
  • Ni Xie — Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Alexandra Tolia",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Frank Kalkbrenner",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Ni Xie",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Chris Buyse",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "onafhankelijke bestuurder",
      "person": {
        "rrn": null,
        "name": "Russeil Greig",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "John de Koning",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Vincent Ossipow",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "onafhankelijke bestuurder",
      "person": {
        "rrn": null,
        "name": "Vincent Brichard",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}
07-02-2022 1 director appointed, 1 resigning Director changes
  • Didier Delanoye — Commissaris
  • Pieter-Jan Van Durme — Commissaris
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Pieter-Jan Van Durme",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Didier Delanoye",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}
2021
03-12-2021 KALKBRENNER Frank Axel appointed as gewone bestuurder Director changes
  • KALKBRENNER Frank Axel — Gewone bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "gewone bestuurder",
      "person": {
        "rrn": null,
        "name": "KALKBRENNER Frank Axel",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "eTheRNA Immunotherapies"
  }
}
04-02-2021 Capital increase of €11,164,320 to €12,203,770.09 Capital & shares
  • €1.039.450,09 → €12.203.770,09
  • Inbreng in geld · Apport en numéraire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 12203770.09,
      "delta_eur": 11164320.0,
      "before_eur": 1039450.09,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}
04-02-2021 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  },
  "legal_form_change": {
    "new": "",
    "old": "Naamloze vennootschap",
    "changed": false
  }
}
2020
11-08-2020 Publication in the Belgian Official Gazette — Miscellaneous Miscellaneous·Marc SLEDSENS
Summary: otherNotary: Marc SLEDSENS · AntwerpenFirm: Deckers notarissen
Technical details 
{
  "stage": null,
  "notary": {
    "name": "Marc SLEDSENS",
    "firm_city": null,
    "firm_name": "Deckers notarissen",
    "office_city": "Antwerpen",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2020-08-11",
    "filing_date": "2020-08-07",
    "act_kind_objet": "KAPITAAL, AANDELEN, DIVERSEN"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2020-07-31",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0502.703.389",
        "name": "ETHERNA IMMUNOTHERAPIES",
        "role": "other",
        "address": "Galileilaan 19, 2845 Niel",
        "is_foreign": false,
        "legal_form": "Naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "7:155",
      "7:180",
      "184 WIB"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 35311,
    "real_estate_included": false,
    "patrimony_description": "De kapitaalverhoging vindt plaats door inbreng in geld. Het geplaatste kapitaal wordt verhoogd van \u20AC992.185,81 naar \u20AC1.039.450,09. Daarnaast worden nieuwe Bevoorrechte Klasse B Aandelen, Additionele Klasse B Anti-dilutie Warrants en Stock Optie Warrants uitgegeven.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES",
    "legal_form": "Naamloze vennootschap"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Marc SLEDSENS",
    "org_rep_person_name": null
  },
  "summary_narrative": "De buitengewone algemene vergadering van aandeelhouders van ETHERNA IMMUNOTHERAPIES besliste een kapitaalverhoging met \u20AC47.264,28 door de uitgifte van 35.311 Bevoorrechte Klasse B Aandelen in geld. Daarnaast werden 3 Additionele Klasse B Anti-dilutie Warrants en 58.361 Stock Optie Warrants uitgegeven. Het kapitaal werd verhoogd tot \u20AC1.039.450,09. De uitoefening van de opties is afhankelijk van de uitgifte van de opties en leidt tot verdere kapitaalverhoging. De commissaris werd vervangen door Pieter-Jan Van Durme.",
  "co_filed_documents": [
    "afschrift van de akte",
    "volmachten",
    "verslagen van de raad van bestuur en verslag van de commissaris, opgesteld in toepassing van de artikelen 7:155 en 7:180 van het WVV",
    "Bijlage 6.1 Additionele Klasse B Anti-dilutie Warrants",
    "Aandelenoptieplan 2020"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "capital_shares"
}
11-08-2020 Capital increase of €47,264.28 to €1,039,450.09 Capital & shares
  • €992.185,81 → €1.039.450,09
  • Inbreng in geld · Apport en numéraire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 1039450.09,
      "delta_eur": 47264.27999999991,
      "before_eur": 992185.81,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}
07-07-2020 1 director appointed, 1 resigning Director changes
  • Kenneth Wils — Bestuurder
  • Chris De Jonghe — Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Chris De Jonghe",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Kenneth Wils",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "eTheRNA Immunotherapies"
  }
}
01-07-2020 2 directors appointed, 1 resigning Director changes
  • YIJUN Chen — Bestuurder
  • XIE Ni — Bestuurder
  • Chris DE JONGHE — Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Chris DE JONGHE",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "YIJUN Chen",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "XIE Ni",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}
01-07-2020 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  },
  "legal_form_change": {
    "new": "Naamloze vennootschap",
    "old": "Naamloze vennootschap",
    "changed": false
  }
}
01-07-2020 Capital increase of €25,966,961 to €26,754,470.57 Capital & shares
  • €787.509,57 → €26.754.470,57
  • Inbreng in geld · Apport en numéraire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 26754470.57,
      "delta_eur": 25966961.0,
      "before_eur": 787509.57,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}
06-05-2020 Deloitte Bedrijfsrevisoren appointed as statutory auditor Director changes
  • Deloitte Bedrijfsrevisoren — Commissaris
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Deloitte Bedrijfsrevisoren",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "eTheRNA immunotherapies"
  }
}
First 30 of 49 acts
Credit advice verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms — you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.
AI due-diligence brief Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.
Company registry (CBE) Crossroads Bank
Activities
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72109Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72190Vervaardiging van farmaceutische grondstoffen21100Vervaardiging van farmaceutische grondstoffen21100Vervaardiging van overige farmaceutische producten21209Vervaardiging van overige farmaceutische producten21209Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies70200Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering70220Speur- en ontwikkelingswerk op biotechnologisch gebied72101Speur- en ontwikkelingswerk op biotechnologisch gebied72110
Primary activity highlighted.
Names & trade names
Legal nameNL ETHERNA IMMUNOTHERAPIES
Registered office
Galileilaan 19
2845 Niel, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies Same NACE
iFLUX BE 0683.854.156 · Niel
4Nature BE 0747.519.810 · Antwerpen
ALCHYMIA BE 0550.713.243 · Antwerpen
ALEXANDER TECHNIEK EDEGEM BE 0682.642.151 · Edegem
All For Research BE 0637.906.048 · Antwerpen
Source: Belgian State Gazette, CBE, NBB · generated via checked.be · indicative